Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma

Affiliations

• ¹ Department of Pathology, Division of Neuropathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
• ² Pathobiology and Translational Sciences Program, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
• ³ Neurosciences Curriculum, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
• ⁴ Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
• ⁵ Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
• ⁶ Department of Neurosurgery and Glioblastoma Translational Center of Excellence, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ⁷ Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, San Diego, California, USA.
• ⁸ Ludwig Cancer Research, San Diego, California, USA.